企業プロフィール
CVRx 株価・ニュース・カタリスト
- ティッカー:
- CVRX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
2.75 USD (-10.71%)
終値
最終更新: 2026年8月17日
144M USD
時価総額
株価変動の要因
As of Aug 17, 2026, CVRX closed down 10.7% at $2.75. No new same-company headline was identified in the current news window.
企業概要
Cardiovascular Neuromodulation
CVRx is a commercial-stage medical-device company focused on neuromodulation therapies for cardiovascular disease. Its technology electrically activates the body's baroreflex to influence autonomic pathways involved in heart-failure progression.
Barostim Platform
Barostim is the company's implantable therapy for patients with heart failure who remain symptomatic despite guideline-directed medical management. The system is placed by trained physicians and supported through a specialized implanting-center network. CVRx is conducting BENEFIT-HF, a randomized controlled study designed to evaluate Barostim's effect on mortality and heart-failure decompensation in an expanded patient population. The trial complements the company's commercial evidence-generation strategy.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。